ArticleCancers2024

Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.

Mehmet Fatih Ozbay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.